S
Sang-A Frontec Co Ltd
KOSDAQ:089980
Sang-A Frontec Co Ltd
KOSDAQ:089980
Price:
18 370
KRW
-5.79%
Market Closed
Market Cap:
286.4B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Sang-A Frontec Co Ltd
18370
-1130 (-5.79%)
| 52 Week Range |
18 370
28 450
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Sang-A Frontec Co Ltd
Balance Sheet
Balance Sheet Decomposition
Sang-A Frontec Co Ltd
Sang-A Frontec Co Ltd
| Current Assets | 158.9B |
| Cash & Short-Term Investments | 51.2B |
| Receivables | 39.8B |
| Other Current Assets | 68B |
| Non-Current Assets | 205.7B |
| Long-Term Investments | 854.4m |
| PP&E | 194.3B |
| Intangibles | 771.6m |
| Other Non-Current Assets | 9.8B |
| Current Liabilities | 164.7B |
| Accounts Payable | 17.7B |
| Accrued Liabilities | 1.8B |
| Short-Term Debt | 71.5B |
| Other Current Liabilities | 73.6B |
| Non-Current Liabilities | 9.1B |
| Long-Term Debt | 1.7B |
| Other Non-Current Liabilities | 7.3B |
Balance Sheet
Sang-A Frontec Co Ltd
Sang-A Frontec Co Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
9 110
|
11 739
|
7 823
|
19 563
|
17 216
|
10 243
|
16 688
|
17 617
|
19 285
|
19 494
|
|
| Cash |
2
|
10
|
3
|
3
|
9
|
10
|
15
|
10
|
18
|
8
|
|
| Cash Equivalents |
9 108
|
11 729
|
7 820
|
19 560
|
17 207
|
10 233
|
16 673
|
17 607
|
19 267
|
19 486
|
|
| Short-Term Investments |
7 448
|
1 140
|
2 365
|
23 658
|
28 660
|
30 400
|
45 597
|
30 983
|
24 545
|
32 383
|
|
| Total Receivables |
26 905
|
34 676
|
42 947
|
39 222
|
44 911
|
63 552
|
64 549
|
66 108
|
52 727
|
45 100
|
|
| Accounts Receivables |
25 338
|
33 875
|
42 581
|
38 857
|
44 714
|
62 958
|
63 896
|
65 665
|
52 337
|
44 822
|
|
| Other Receivables |
1 567
|
801
|
366
|
365
|
197
|
594
|
653
|
442
|
390
|
278
|
|
| Inventory |
19 874
|
21 272
|
20 476
|
20 263
|
31 380
|
24 306
|
29 724
|
38 261
|
52 507
|
53 234
|
|
| Other Current Assets |
1 843
|
5 569
|
7 754
|
2 519
|
2 598
|
3 081
|
3 248
|
10 696
|
10 419
|
8 259
|
|
| Total Current Assets |
65 179
|
74 396
|
81 366
|
105 225
|
124 765
|
131 581
|
159 805
|
163 664
|
159 483
|
158 470
|
|
| PP&E Net |
86 212
|
101 834
|
102 380
|
105 236
|
104 807
|
107 223
|
113 566
|
145 911
|
161 985
|
178 870
|
|
| PP&E Gross |
86 212
|
101 834
|
102 380
|
105 236
|
104 807
|
107 223
|
113 566
|
145 911
|
161 985
|
178 870
|
|
| Accumulated Depreciation |
41 812
|
48 684
|
54 785
|
61 386
|
67 333
|
74 616
|
78 742
|
86 048
|
94 471
|
105 019
|
|
| Intangible Assets |
1 509
|
1 567
|
1 523
|
1 438
|
1 530
|
817
|
801
|
852
|
822
|
801
|
|
| Note Receivable |
0
|
0
|
5 012
|
5 548
|
5 671
|
6 366
|
6 040
|
4 569
|
7 117
|
4 030
|
|
| Long-Term Investments |
799
|
1 136
|
1 467
|
988
|
976
|
1 579
|
1 061
|
1 263
|
1 553
|
382
|
|
| Other Long-Term Assets |
1 066
|
1 881
|
10 226
|
1 486
|
1 307
|
752
|
2 074
|
3 309
|
4 999
|
6 400
|
|
| Total Assets |
154 764
N/A
|
180 814
+17%
|
201 974
+12%
|
219 921
+9%
|
239 056
+9%
|
248 318
+4%
|
283 345
+14%
|
319 567
+13%
|
335 959
+5%
|
348 952
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
10 805
|
10 631
|
12 181
|
15 916
|
17 863
|
13 922
|
19 442
|
17 116
|
14 949
|
16 850
|
|
| Accrued Liabilities |
481
|
586
|
830
|
1 092
|
1 076
|
1 362
|
1 430
|
1 359
|
1 650
|
1 519
|
|
| Short-Term Debt |
36 290
|
44 366
|
54 274
|
40 317
|
60 957
|
65 122
|
63 097
|
54 116
|
68 463
|
60 651
|
|
| Current Portion of Long-Term Debt |
5 030
|
2 958
|
1 938
|
12 701
|
25 794
|
5 922
|
2 760
|
8 083
|
35 901
|
2 292
|
|
| Other Current Liabilities |
5 858
|
8 613
|
8 631
|
11 062
|
8 725
|
7 371
|
7 358
|
15 113
|
13 861
|
11 670
|
|
| Total Current Liabilities |
58 464
|
67 154
|
77 855
|
81 088
|
114 415
|
93 699
|
94 087
|
95 788
|
134 824
|
92 983
|
|
| Long-Term Debt |
7 405
|
16 046
|
21 519
|
26 347
|
562
|
5 391
|
31 982
|
35 811
|
9 594
|
38 494
|
|
| Deferred Income Tax |
3 982
|
3 391
|
2 384
|
2 068
|
2 590
|
2 479
|
4 362
|
3 877
|
3 437
|
5 163
|
|
| Other Liabilities |
628
|
1 621
|
1 817
|
934
|
2 272
|
2 943
|
2 897
|
2 491
|
3 117
|
19 286
|
|
| Total Liabilities |
70 479
N/A
|
88 212
+25%
|
103 574
+17%
|
110 437
+7%
|
119 838
+9%
|
104 513
-13%
|
133 329
+28%
|
137 967
+3%
|
150 973
+9%
|
155 926
+3%
|
|
| Equity | |||||||||||
| Common Stock |
6 268
|
6 464
|
6 651
|
7 132
|
7 132
|
7 656
|
7 862
|
7 995
|
7 995
|
7 995
|
|
| Retained Earnings |
58 946
|
64 791
|
68 239
|
74 245
|
83 764
|
93 730
|
93 711
|
102 339
|
107 980
|
116 233
|
|
| Additional Paid In Capital |
19 662
|
21 702
|
23 647
|
28 699
|
28 699
|
42 514
|
54 128
|
67 582
|
64 401
|
60 068
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 473
|
5 806
|
|
| Treasury Stock |
1 019
|
796
|
529
|
529
|
529
|
529
|
5 858
|
4 405
|
4 405
|
4 405
|
|
| Other Equity |
429
|
441
|
392
|
63
|
153
|
434
|
172
|
8 090
|
7 542
|
7 330
|
|
| Total Equity |
84 285
N/A
|
92 602
+10%
|
98 400
+6%
|
109 484
+11%
|
119 217
+9%
|
143 805
+21%
|
150 017
+4%
|
181 600
+21%
|
184 986
+2%
|
193 026
+4%
|
|
| Total Liabilities & Equity |
154 764
N/A
|
180 814
+17%
|
201 974
+12%
|
219 921
+9%
|
239 056
+9%
|
248 318
+4%
|
283 345
+14%
|
319 567
+13%
|
335 959
+5%
|
348 952
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
12
|
13
|
13
|
14
|
14
|
15
|
15
|
16
|
16
|
16
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
